Literature DB >> 4333547

Immunoelectrophoretic analysis of avian ribonucleic acid tumor virus group-specific antigens.

R A Bonar, R Ishizaki, J W Beard.   

Abstract

Tumors induced in pigeons by inoculation with the Schmidt-Ruppin strain of Rous sarcoma virus regressed after about 6 weeks. Sera from these pigeons, taken 8 weeks after inoculation, had complement-fixing group-specific antibody titers of 1:2 to 1:256. In immunoelectrophoresis with the pigeon serum, disrupted BAI strain A (myeloblastosis) avian tumor virus showed at least five precipitin arcs. The pattern of precipitin lines was dependent in part on the means used for virus disruption, and ethyl ether and nonionic detergents appeared to be both effective and relatively mild reagents. Immunoelectrophoretic comparison of pigeon serum with serum from a tumor-bearing hamster and that from virus-inoculated rabbits yielded similar, though not identical, results.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4333547      PMCID: PMC356266     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  AN AVIAN LEUCOSIS GROUP-SPECIFIC COMPLEMENT FIXATION REACTION. APPLICATION FOR THE DETECTION AND ASSAY OF NON-CYTOPATHOGENIC LEUCOSIS VIRUSES.

Authors:  P S SARMA; H C TURNER; R J HUEBNER
Journal:  Virology       Date:  1964-07       Impact factor: 3.616

2.  SPECIFIC COMPLEMENT-FIXING VIRAL ANTIGENS IN HAMSTER AND GUINEA PIG TUMORS INDUCED BY THE SCHMIDT-RUPPIN STRAIN OF AVIAN SARCOMA.

Authors:  R J HUEBNER; D ARMSTRONG; M OKUYAN; P S SARMA; H C TURNER
Journal:  Proc Natl Acad Sci U S A       Date:  1964-05       Impact factor: 11.205

3.  STUDIES ON THE BAI STRAIN A (AVIAN MYELOBLASTOSIS) VIRUS. I. PRODUCTION AND EXAMINATION OF POTENT VIRUS-SPECIFIC COMPLEMENT-FIXING ANTISERA.

Authors:  E A ECKERT; R ROTT; W SCHAEFER
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

4.  STUDIES ON THE BAI STRAIN A (AVIAN MYELOBLASTOSIS) VIRUS. II. SOME PROPERTIES OF VIRAL SPLIT PRODUCTS.

Authors:  E A ECKERT; R ROTT; W SCHAEFER
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

5.  Virus of avian myeloblastosis. XII. Chemical constitution.

Authors:  R A BONAR; J W BEARD
Journal:  J Natl Cancer Inst       Date:  1959-07       Impact factor: 13.506

6.  Proteins of Rous sarcoma virus.

Authors:  P H Duesberg; H L Robinson; W S Robinson; R J Huebner; H C Turner
Journal:  Virology       Date:  1968-09       Impact factor: 3.616

7.  Specific complement fixation test of Rous sarcoma with pigeon serum.

Authors:  H Sazawa; T Sugimori; Y Miura; T Shimizu
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1966

8.  Immunological relationships among envelope antigens of avian tumor viruses.

Authors:  R Ishizaki; P K Vogt
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

9.  Susceptibility and immunity in pigeons to Schmidt-Ruppin strain of Rous sarcoma virus.

Authors:  H Sazawa; M Watanabe
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1966

10.  Origin of group-specific antigen of chicken leukosis viruses.

Authors:  H Bauer; W Schäfer
Journal:  Virology       Date:  1966-07       Impact factor: 3.616

View more
  4 in total

1.  Isolation of two subgroup-specific leukemogenic viruses from standard avian myeloblastosis virus.

Authors:  R Ishizaki; A J Langlois; D P Bolognesi
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  Chromatographic and electrophoretic analysis of viral proteins from hamster and chicken cells transformed by Rous sarcoma virus.

Authors:  E Fleissner; E Tress
Journal:  J Virol       Date:  1973-02       Impact factor: 5.103

3.  Avian sarcoma virus-transformed quail clones defective in the production of focus-forming virus.

Authors:  W S Mason; T W Hsu; C Yeater; J L Sabran; G E Mark; A Kaji; J M Taylor
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

4.  Outer membrane of avian myeloblastosis virus.

Authors:  R Ishizaki; R B Luftig; D P Bolognesi
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.